Article

Prostate cancer recurrence may be reduced by folic acid

A study from Duke University, Durham, NC suggests that folic acid may reduce the risk of prostate cancer recurrence following radical prostatectomy.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
John P. Sfakianos, MD, on the role of urine-based biomarkers in microhematuria evaluation
John P. Sfakianos, MD, on the role of urine-based biomarkers in microhematuria evaluation
Recurrent uUTI guideline: Renewed emphasis on symptom resolution
Recurrent uUTI guideline: Renewed emphasis on symptom resolution
Manuj Agarwal, MD, on patient selection for prostate brachytherapy
Manuj Agarwal, MD, on patient selection for prostate brachytherapy
Related Content
Site Logo
September 18th 2025

How Quality Real-World Evidence Is Transforming Clinical Practice in Prostate Cancer Treatment

Pearls & Perspectives: Optimizing Outcomes in Prostate Cancer, with Mark L. Gonzalgo, MD, PhD
September 18th 2025

Pearls & Perspectives: Optimizing Outcomes in Prostate Cancer, with Mark L. Gonzalgo, MD, PhD

Amy M. Pearlman, MD
Study highlights gaps in PCP knowledge on PSA testing for Black men
September 18th 2025

Study highlights gaps in PCP knowledge on PSA testing for Black men

Hannah Clarke
Pearls & Perspectives: Prostate MRI and Focal Therapy, with Dan Sperling, MD, DABR
September 18th 2025

Pearls & Perspectives: Prostate MRI and Focal Therapy, with Dan Sperling, MD, DABR

Amy M. Pearlman, MD
Andrew J. Kirsch, MD, FAAP, FACS
September 18th 2025

A pediatric urologist outlines gaps and opportunities in enuresis treatment

Andrew J. Kirsch, MD, FAAP, FACS
First PCNL procedures with Focalist handheld robotic system debut at WCET
September 18th 2025

First PCNL procedures with Focalist handheld robotic system debut at WCET

Hannah Clarke
© 2025 MJH Life Sciences

All rights reserved.